INTERNATIONAL MEDICAL FORUM:
REALIZING THE GOAL OF CURING GOUT
From “Curable in principle” to “Curable – Achievable – Verifiable”
Global – Online – Living Forum | Initiated by Vien Gut (Ho Chi Minh City, Viet Nam)
—– —— —–
(For Footer/About use; positioned as the “Reference Case” for the International Consensus Forum)
Vien Gut is a legally operating medical and scientific center in Ho Chi Minh City, consisting of two closely integrated components:
Vien Gut General Clinic – licensed by the Ho Chi Minh City Department of Health since 2008; provides outpatient diagnosis and treatment for gout and related chronic diseases, with a long-term journey-based governance model prioritizing patient safety.
Research Center for Gout and Chronic Diseases – licensed by the Ho Chi Minh City Department of Science and Technology since 2011; conducts scientific research, aggregates real-world data, develops care models, and contributes academically in the fields of gout and complex chronic multimorbidity.
Within the Forum, Vien Gut is presented as a Reference Case to demonstrate the feasibility of making the goal of “cure – achievable – verifiable” real in long-term outpatient clinical practice.
Core specialty focus: gout and related chronic conditions with multi-organ interaction, especially in the context of complex chronic multimorbidity.
Priority populations: patients with severe/complicated gout and/or multiple chronic comorbidities, often falling outside the full coverage zone of single-disease guidelines.
Treatment orientation: long-term outpatient care with longitudinal follow-up, prioritizing vital-organ safety, proactive risk control, reducing treatment discontinuity, and reducing relapse caused by “journey abandonment.”
Journey-based care organization: approaching the patient as an integrated “reference system,” prioritizing identification of risk axes and breakpoints of decompensation episodes.
Clinical responsibility coordination: deploying a Clinical Conductor physician role to coordinate a multidisciplinary team, aligning treatment goals across comorbidities and reducing conflicts between single-disease recommendations within the same patient.
Safe outpatient governance: establishing intake principles, risk screening, and referral thresholds to keep the long-term journey within a defined “safety boundary.”
Diagnostic foundation: objective-criteria orientation and “right test in the right context” indication principles, ensuring diagnostic reliability and disease severity stratification.
Visual-medicine longitudinal monitoring: using before–after imaging and scheduled monitoring to reinforce adherence and to build the basis for time-based verification of treatment outcomes.
Verification principle: organizing repeated verification checkpoints to confirm an achieved state “at the time of assessment” (verification at assessment), aligned with the logic of “verifiable in real-world practice.”
Vien Gut operates a structured operational layer to translate long-term treatment goals into repeatable, transferable actions, including:
Risk stratification & red-flag screening: defining safe outpatient eligibility, alert thresholds, and referral thresholds.
Phase-based pain governance: symptom control during crystal dissolution phases to reduce journey abandonment risk.
Polypharmacy & interaction governance: multi-layer control mechanisms to reduce toxicity and drug–drug / drug–organ interactions in organ impairment and multimorbidity contexts.
Trend-based longitudinal monitoring: time-variation-driven operation with alert thresholds and response scenarios.
Two-way referral safety valve: proactive transfer when outside safety boundaries and reintegration after discharge to continue the journey.
SOP/WI and operational forms package: standardizing quality, reducing dependence on individuals, increasing scalability/replicability.
Data for operations (“data-to-operate”): prioritizing decision-support data, trend monitoring, and risk governance.
Structured longitudinal tracking: minimum data for dashboards, multi-layer alerts, and timeline-based progress monitoring.
Decision traceability (decision log/audit trail): enabling transparency, quality control, and academic synthesis readiness.
Data and imaging governance: access control, audit trails, tiered consent governance, and standardized reporting for synthesis.
Operations-linked research: driven by implementation gaps and the need to standardize the “HOW” of long-term outpatient practice.
Multidisciplinary collaboration: expanding collaboration across gout, cardiology, nephrology/urology, hepatology, diabetes, imaging, immunology, biostatistics, and related fields to strengthen standardization and evidence synthesis capacity.
Role in the Forum: providing real-world context and operational experience to support consensus on goal–criteria–verification frameworks.
Minimum transfer package: operational-layer blueprint, SOP/WI set, role-based training framework, minimum data framework, and risk-control principles.
LMIC-first orientation: resource optimization, reduced dependence on high-end infrastructure, emphasis on stratification, safety, longitudinal monitoring, and operational standardization.
Transfer objective: supporting healthcare facilities to build long-term outpatient pathways that are operational and verifiable in real practice.
The Vien Gut General Clinic and the Vien Gut Research Center are included in the Forum profile as a Reference Case to demonstrate feasibility in operationalizing the goal of “cure – achievable – verifiable” in long-term outpatient operations. This capability profile is intended to support the translation chain: principle → goal → criteria → confirmatory research → verifiable practice, and does not replace the consensus roles of guideline groups and outcome-standardization organizations.